Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VCAM1 | P19320 | 18/20 | 0.71 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.59 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30430066 | 1.00 | VCAM1 (0.71) | VCAM1NPBWR1MCHR1ALDH1A1 | |
| Methyl Alcohol SCHEMBL29280927 | 0.95 | VCAM1 (0.65) | VCAM1NPBWR1MCHR1ALDH1A1 | |
| SCHEMBL7721899 | 0.90 | VCAM1 (0.59) | VCAM1NPBWR1MCHR1ALDH1A1 | |
| SCHEMBL10452716 | 0.86 | VCAM1 (0.73) | VCAM1NPBWR1MCHR1ALDH1A1 | |
| SCHEMBL29780388 | 0.86 | VCAM1 (0.73) | VCAM1NPBWR1MCHR1ALDH1A1 | |
| SCHEMBL809482 | 0.86 | VCAM1 (0.73) | VCAM1NPBWR1MCHR1ALDH1A1 | |
| SCHEMBL8675051 | 0.86 | VCAM1 (0.55) | VCAM1NPBWR1MCHR1ALDH1A1 | |
| SCHEMBL9323485 | 0.85 | VCAM1 (0.71) | VCAM1NPBWR1MCHR1ALDH1A1 | |
| SCHEMBL5925285 | 0.85 | MMP1 (0.65) | VCAM1NPBWR1MCHR1 | |
| SCHEMBL3813276 | 0.84 | VCAM1 (0.50) | VCAM1NPBWR1MCHR1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 816 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119425423-A | Positively charged composite membrane and preparation method and application thereof | 中国石油化工股份有限公司 | 2025-02-14 | — | — | CN | claimed |
| CN-119143705-A | Benzofuran lymph specific tyrosine phosphatase inhibitor and preparation method and application thereof | 山东大学 | 2024-12-17 | — | — | CN | claimed |
| CN-117820417-A | Near-infrared bimodal optical probe and preparation method and application thereof | 中国药科大学 | 2024-04-05 | — | — | CN | claimed |
| CN-115710251-A | Myeloid differentiation factor 88 inhibitor and preparation method and application thereof | 杭州医学院 | 2023-02-24 | — | — | CN | claimed |
| CN-109694338-B | Methoxy acetophenone derivative and preparation method and application thereof | 河南科技大学 | 2021-09-24 | — | — | CN | claimed |
| CN-109516987-B | Preparation method of avibactam intermediate | 江西富祥药业股份有限公司 | 2020-07-24 | — | — | CN | claimed |
| CN-106568857-B | A method of the related substance of measurement palm pipotiazine | 岳阳新华达制药有限公司 | 2019-08-06 | — | — | CN | claimed |
| CN-105669502-A | Chromogenic substrate of 3-nitro-4-chlorine-benzenesulfonamide glutathione-S-transsulfurase | 重庆医科大学 | 2016-06-15 | — | — | CN | claimed |
| CN-1267414-C | Separating purification of 3-nitro-4-chlorofenizon | SHANGHAI APPLIED TECHNOLOGY CO (CN) | 2006-08-02 | — | — | CN | claimed |
| CN-1680309-A | Separating purification of 3-nitro-4-chlorofenizon | SHANGHAI APPLIED TECHNOLOGY CO (CN) | 2005-10-12 | — | — | CN | claimed |
| EP-0248334-B1 | PROCESS FOR THE MANUFACTURE OF 2-NITRO-4-SULFAMYL-DIPHENYL AMINE DYES | HOECHST AKTIENGESELLSCHAFT (DE) | 1993-01-13 | — | — | EP | claimed |
| US-4851575-A | Process for the preparation of 2-nitro-4-sulfamyldiphenylamine dyestuffs | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-07-25 | — | — | US | claimed |
| EP-0289847-A1 | Preparation of 2-Chloro-5-nitro- and 4-Chloro-3-nitrobenzene-sulfonyl chloride | BAYER AG (DE) | 1988-11-09 | — | — | EP | claimed |
| JP-6329618-A | — | — | None | — | — | JP | disclosed |
| CN-122071469-A | PARG inhibitor and preparation method and application thereof | 烟台新药创制山东省实验室 | 2026-05-22 | — | — | CN | disclosed |
| US-20260049088-A1 | TRICYCLIC HETEROCYCLIC DERIVATIVES, COMPOSITIONS AND USES THEREOF | DANATLAS PHARMACEUTICALS CO LTD (CN) | 2026-02-19 | — | — | US | disclosed |
| US-3954476-A | Diffusable dye-releasing compounds which are cleavable upon oxidation | EASTMAN KODAK COMPANY (US) | 1976-05-04 | — | — | US | disclosed |
| US-3945992-A | DISAZO DYES FOR POLYAMIDES | BAYER AKTIENGESELLSCHAFT (DT) | 1976-03-23 | — | — | US | disclosed |
| US-3945991-A | Heterocyclic azo compounds containing a quaternated hydrazide group | CIBA-GEIGY AG (CH) | 1976-03-23 | — | — | US | disclosed |
| US-3932380-A | DIFFUSION TRANSFER COLOR PHOTOGRAPHY | EASTMAN KODAK COMPANY (US) | 1976-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260049088-A1 | TRICYCLIC HETEROCYCLIC DERIVATIVES, COMPOSITIONS AND USES THEREOF | SRD5A2, CBR1, SRD5A1 | VCAM1 4636/4885NPBWR1 360/4885MCHR1 257/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.